Related Experiment Videos
Human immunodeficiency virus infection in a Dublin general practice
Summary
This Dublin general practice observed a high human immunodeficiency virus (HIV) seropositivity rate of 35% among intravenous drug users, significantly exceeding the national average. This highlights the critical need for targeted interventions within this vulnerable population.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- A Dublin inner-city group general practice has managed intravenous drug users (IDUs) since the late 1970s.
- The practice has documented 54 human immunodeficiency virus (HIV)-seropositive patients since 1985.
Purpose of the Study:
- To assess the prevalence of HIV infection within a cohort of patients attending a Dublin general practice.
- To compare the HIV seropositivity rate among local intravenous drug users with national figures.
Main Methods:
- Retrospective review of patient records from a Dublin inner-city general practice.
- Analysis of HIV serostatus among all patients, with a specific focus on intravenous drug users.
Main Results:
- Of 54 HIV-seropositive patients, 48 were intravenous drug users, 4 were children of drug users, and 2 were infected sexually.
- Three patients developed acquired immune deficiency syndrome (AIDS), and at least eight had symptomatic HIV disease.
- The practice identified a 35% HIV seropositivity rate among its known intravenous drug users (48/137), substantially higher than the national average of 16% for tested IDUs.
Conclusions:
- Intravenous drug abuse is a primary driver of HIV infection in Ireland.
- The study practice exhibits a disproportionately high prevalence of HIV among its intravenous drug user population compared to national rates.
- This underscores the importance of localized, targeted HIV prevention and management strategies for high-risk groups.